Benzo[a]pyrene and glycine N-methyltransferse Interactions: Gene expression profiles of the liver detoxification pathway

Toxicology and Applied Pharmacology

Volumn 214, Issue 2, 2006, Pages 126-135

  Lee, Cheng Ming ^a   Chen, Shih Yin ^a   Lee, Yuan Chii G ^b   Huang, Chi Ying F ^b   Chen, Yi Ming Arthur ^a  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

Author keywords

Benzo a pyrene; Detoxification pathway; DNA arrays; Gene expression; GNMT

Indexed keywords

BENZO[A]PYRENE; COMPLEMENTARY DNA; ENZYME; GLYCINE METHYLTRANSFERASE; PHOSPHATASE; PHOSPHOTRANSFERASE; UNCLASSIFIED DRUG;

ARTICLE; CELL STRAIN HEPG2; CONTROLLED STUDY; CYTOTOXICITY; DETOXIFICATION; DNA MICROARRAY; GENE EXPRESSION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; LIVER TOXICITY; ONCOGENE; REAL TIME POLYMERASE CHAIN REACTION;

BENZO(A)PYRENE; CELL LINE, TUMOR; CELL SURVIVAL; CLUSTER ANALYSIS; DOWN-REGULATION; GENE EXPRESSION PROFILING; GLYCINE N-METHYLTRANSFERASE; HUMANS; LIVER; METABOLIC DETOXICATION, DRUG; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; POLYMERASE CHAIN REACTION; PROTEIN BINDING; RECEPTORS, CYTOPLASMIC AND NUCLEAR; UP-REGULATION;

EID: 33745865936     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2005.12.020     Document Type: Article

References (40)

1. Aden D.P., Fogel A., Plotkin S., Damjanov I., and Knowles B.B. Controlled synthesis of HBsAg in a differentiated human liver carcinoma-derived cell line. Nature 282 (1979) 615-616
2. Bartosiewicz M., Penn S., and Buckpitt A. Applications of gene arrays in environmental toxicology: fingerprints of gene regulation associated with cadmium chloride, benzo(a)pyrene, and trichloroethylene. Environ. Health Perspect. 109 (2001) 71-74
3. Blumenstein J., and Williams G.R. Glycine methyltransferase. Can. J. Biochem. Physiol. 41 (1963) 201-210
4. Brazma A., Hingamp P., Quackenbush J., Sherlock G., Spellman P., Stoeckert C., Aach J., Ansorge W., Ball C.A., Causton H.C., Gaasterland T., Glenisson P., Holstege F.C., Kim I.F., Markowitz V., Matese J.C., Parkinson H., Robinson A., Sarkans U., Schulze-Kremer S., Stewart J., Taylor R., Vilo J., and Vingron M. Minimum information about a microarray experiment (MIAME)-toward standards for microarray data. Nat. Genet. 29 (2001) 365-371
5. Buesen R., Mock M., Seidel A., Jacob J., and Lampen A. Interaction between metabolism and transport of benzo[a]pyrene and its metabolites in enterocytes. Toxicol. Appl. Pharmacol. 183 (2002) 168-178
6. Buesen R., Mock M., Nau H., Seidel A., Jacob J., and Lampen A. Human intestinal Caco-2 cells display active transport of benzo[a]pyrene metabolites. Chem. Biol. Interact. 142 (2003) 201-221
7. Burczynski M.E., Lin H.K., and Penning T.M. Isoform-specific induction of a human aldo-keto reductase by polycyclic aromatic hydrocarbons (PAHs), electrophiles, and oxidative stress: implications for the alternative pathway of PAH activation catalyzed by human dihydrodiol dehydrogenase. Cancer Res. 59 (1999) 607-614
8. Chen Y.M., Chen L.Y., Wong F.H., Lee C.M., Chang T.J., and Yang-Feng T.L. Genomic structure, expression, and chromosomal localization of the human glycine N-methyltransferase gene. Genomics 66 (2000) 43-47
9. Chen S.Y., Lin J.R., Darbha R., Lin P., Liu T.Y., and Chen Y.M. Glycine N-methyltransferase tumor susceptibility gene in the benzo(a)pyrene-detoxification pathway. Cancer Res. 64 (2004) 3617-3623
10. Cook R.J., and Wagner C. Glycine N-methyltransferase is a folate binding protein of rat liver cytosol. Proc. Natl. Acad. Sci. U.S.A. 81 (1984) 3631-3634
11. Dearfield K.L., Jacobson-Kram D., Brown N.A., and Williams J.R. Evaluation of a human hepatoma cell line as a target cell in genetic toxicology. Mutat. Res. 108 (1983) 437-449
12. Denissenko M.F., Cahill J., Koudriakova T.B., Gerber N., and Pfeifer G.P. Quantitation and mapping of aflatoxin B1-induced DNA damage in genomic DNA using aflatoxin B1-8,9-epoxide and microsomal activation systems. Mutat. Res. 425 (1999) 205-211
13. Diamond L., Kruszewski F., Aden D.P., Knowles B.B., and Baird W.M. Metabolic activation of benzo[a]pyrene by a human hepatoma cell line. Carcinogenesis 1 (1980) 871-875
14. Diamond L., Cherian K., Harvey R.G., and DiGiovanni J. Mutagenic activity of methyl- and fluoro-substituted derivatives of polycyclic aromatic hydrocarbons in a human hepatoma (HepG2) cell-mediated assay. Mutat. Res. 136 (1984) 65-72
15. Duthie S.J., Coleman C.S., and Grant M.H. Status of reduced glutathione in the human hepatoma cell line, HEP G2. Biochem. Pharmacol. 37 (1988) 3365-3368
16. Eisen M.B., Spellman P.T., Brown P.O., and Botstein D. Cluster analysis and display of genome-wide expression patterns. Proc. Natl. Acad. Sci. U.S.A. 95 (1998) 14863-14868
17. Fang J.L., Beland F.A., Doerge D.R., Wiener D., Guillemette C., Marques M.M., and Lazarus P. Characterization of benzo(a)pyrene-trans-7,8-dihydrodiol glucuronidation by human tissue microsomes and overexpressed UDP-glucuronosyltransferase enzymes. Cancer Res. 62 (2002) 1978-1986
18. Fukuda Y., Ishida N., Noguchi T., Kappas A., and Sassa S. Interleukin-6 down regulates the expression of transcripts encoding cytochrome P450 IA1, IA2 and IIIA3 in human hepatoma cells. Biochem. Biophys. Res. Commun. 184 (1992) 960-965
19. Grant M.H., Duthie S.J., Gray A.G., and Burke M.D. Mixed function oxidase and UDP-glucuronyltransferase activities in the human Hep G2 hepatoma cell line. Biochem. Pharmacol. 37 (1988) 4111-4116
20. Grove A.D., Kessler F.K., Metz R.P., and Ritter J.K. Identification of a rat oltipraz-inducible UDP-glucuronosyltransferase (UGT1A7) with activity towards benzo(a)pyrene-7,8-dihydrodiol. J. Biol. Chem. 272 (1997) 1621-1627
21. Guengerich F.P. Metabolic activation of carcinogens. Pharmacol. Ther. 54 (1992) 17-61
22. Guillemette C., Ritter J.K., Auyeung D.J., Kessler F.K., and Housman D.E. Structural heterogeneity at the UDP-glucuronosyltransferase 1 locus: functional consequences of three novel missense mutations in the human UGT1A7 gene. Pharmacogenetics 10 (2000) 629-644
23. Harrigan J.A., Vezina C.M., McGarrigle B.P., Ersing N., Box H.C., Maccubbin A.E., and Olson J.R. DNA adduct formation in precision-cut rat liver and lung slices exposed to benzo[a]pyrene. Toxicol. Sci. 77 (2004) 307-314
24. Jin C.J., Miners J.O., Burchell B., and Mackenzie P.I. The glucuronidation of hydroxylated metabolites of benzo[a]pyrene and 2-acetylaminofluorene by cDNA-expressed human UDP-glucuronosyltransferases. Carcinogenesis 14 (1993) 2637-2639
25. Josephy P.D. Polycyclic aromatic hydrocarbon carcinogenesis. In: Josephy P.D., Mannervik B., and Ortiz de Montellano P.R. (Eds). Molecular Toxicology (1997), Oxford Univ. Press, New York 334-347
26. Kerr S.J. Competing methyltransferase systems. J. Biol. Chem. 247 (1972) 4248-4252
27. Knowles B.B., Howe C.C., and Aden D.P. Human hepatocellular carcinoma cell lines secrete the major plasma proteins and hepatitis B surface antigen. Science 209 (1980) 497-499
28. Limbosch S. Benzo[a]pyrene- and aldrin-metabolizing activities in cultured human and rat hepatoma cell lines. J. Natl. Cancer Inst. 71 (1983) 281-286
29. Lloyd D.R., and Hanawalt P.C. p53-dependent global genomic repair of benzo[a]pyrene-7,8-diol-9,10-epoxide adducts in human cells. Cancer Res. 60 (2000) 517-521
30. Mojarrabi B., and Mackenzie P.I. Characterization of two UDP glucuronosyltransferases that are predominantly expressed in human colon. Biochem. Biophys. Res. Commun. 247 (1998) 704-709
31. Munzel P.A., Schmohl S., Heel H., Kalberer K., Bock-Hennig B.S., and Bock K.W. Induction of human UDP glucuronosyltransferases (UGT1A6, UGT1A9, and UGT2B7) by t-butylhydroquinone and 2,3,7,8-tetrachlorodibenzo-p-dioxin in Caco-2 cells. Drug Metab. Dispos. 27 (1999) 569-573
32. Palackal N.T., Burczynski M.E., Harvey R.G., and Penning T.M. Metabolic activation of polycyclic aromatic hydrocarbon trans-dihydrodiols by ubiquitously expressed aldehyde reductase (AKR1A1). Chem. Biol. Interact. 130-132 (2001) 815-824
33. Sassa S., Sugita O., Galbraith R.A., and Kappas A. Drug metabolism by the human hepatoma cell, Hep G2. Biochem. Biophys. Res. Commun. 143 (1987) 52-57
34. Shimada T., Yun C.H., Yamazaki H., Gautier J.C., Beaune P.H., and Guengerich F.P. Characterization of human lung microsomal cytochrome P-450 1A1 and its role in the oxidation of chemical carcinogens. Mol. Pharmacol. 41 (1992) 856-864
35. Sladek N.E. Human aldehyde dehydrogenases: potential pathological, pharmacological, and toxicological impact. J. Biochem. Mol. Toxicol. 17 (2003) 7-23
36. Sokal R.R., and Michener C.D. Univ. Kans. Sci. Bull. 38 (1958) 1409-1438
37. Wacher V.J., Wu C.Y., and Benet L.Z. Overlapping substrate specificities and tissue distribution of cytochrome P450 3A and P-glycoprotein: implications for drug delivery and activity in cancer chemotherapy. Mol. Carcinog. 13 (1995) 129-134
38. Wani M.A., Zhu Q., El Mahdy M., Venkatachalam S., and Wani A.A. Enhanced sensitivity to anti-benzo(a)pyrene-diol-epoxide DNA damage correlates with decreased global genomic repair attributable to abrogated p53 function in human cells. Cancer Res. 60 (2000) 2273-2280
39. Wasserman W.W., and Fahl W.E. Functional antioxidant responsive elements. Proc. Natl. Acad. Sci. U.S.A. 94 (1997) 5361-5366
40. Yuen T., Wurmbach E., Pfeffer R.L., Ebersole B.J., and Sealfon S.C. Accuracy and calibration of commercial oligonucleotide and custom cDNA microarrays. Nucleic Acids Res. 30 (2002) e48